NZ Herald
  • Home
  • Latest news
  • Herald NOW
  • Video
  • New Zealand
  • Sport
  • World
  • Business
  • Entertainment
  • Podcasts
  • Quizzes
  • Opinion
  • Lifestyle
  • Travel
  • Viva
  • Weather

Subscriptions

  • Herald Premium
  • Viva Premium
  • The Listener
  • BusinessDesk

Sections

  • Latest news
  • New Zealand
    • All New Zealand
    • Crime
    • Politics
    • Education
    • Open Justice
    • Scam Update
  • Herald NOW
  • On The Up
  • World
    • All World
    • Australia
    • Asia
    • UK
    • United States
    • Middle East
    • Europe
    • Pacific
  • Business
    • All Business
    • MarketsSharesCurrencyCommoditiesStock TakesCrypto
    • Markets with Madison
    • Media Insider
    • Business analysis
    • Personal financeKiwiSaverInterest ratesTaxInvestment
    • EconomyInflationGDPOfficial cash rateEmployment
    • Small business
    • Business reportsMood of the BoardroomProject AucklandSustainable business and financeCapital markets reportAgribusiness reportInfrastructure reportDynamic business
    • Deloitte Top 200 Awards
    • CompaniesAged CareAgribusinessAirlinesBanking and financeConstructionEnergyFreight and logisticsHealthcareManufacturingMedia and MarketingRetailTelecommunicationsTourism
  • Opinion
    • All Opinion
    • Analysis
    • Editorials
    • Business analysis
    • Premium opinion
    • Letters to the editor
  • Politics
  • Sport
    • All Sport
    • OlympicsParalympics
    • RugbySuper RugbyNPCAll BlacksBlack FernsRugby sevensSchool rugby
    • CricketBlack CapsWhite Ferns
    • Racing
    • NetballSilver Ferns
    • LeagueWarriorsNRL
    • FootballWellington PhoenixAuckland FCAll WhitesFootball FernsEnglish Premier League
    • GolfNZ Open
    • MotorsportFormula 1
    • Boxing
    • UFC
    • BasketballNBABreakersTall BlacksTall Ferns
    • Tennis
    • Cycling
    • Athletics
    • SailingAmerica's CupSailGP
    • Rowing
  • Lifestyle
    • All Lifestyle
    • Viva - Food, fashion & beauty
    • Society Insider
    • Royals
    • Sex & relationships
    • Food & drinkRecipesRecipe collectionsRestaurant reviewsRestaurant bookings
    • Health & wellbeing
    • Fashion & beauty
    • Pets & animals
    • The Selection - Shop the trendsShop fashionShop beautyShop entertainmentShop giftsShop home & living
    • Milford's Investing Place
  • Entertainment
    • All Entertainment
    • TV
    • MoviesMovie reviews
    • MusicMusic reviews
    • BooksBook reviews
    • Culture
    • ReviewsBook reviewsMovie reviewsMusic reviewsRestaurant reviews
  • Travel
    • All Travel
    • News
    • New ZealandNorthlandAucklandWellingtonCanterburyOtago / QueenstownNelson-TasmanBest NZ beaches
    • International travelAustraliaPacific IslandsEuropeUKUSAAfricaAsia
    • Rail holidays
    • Cruise holidays
    • Ski holidays
    • Luxury travel
    • Adventure travel
  • Kāhu Māori news
  • Environment
    • All Environment
    • Our Green Future
  • Talanoa Pacific news
  • Property
    • All Property
    • Property Insider
    • Interest rates tracker
    • Residential property listings
    • Commercial property listings
  • Health
  • Technology
    • All Technology
    • AI
    • Social media
  • Rural
    • All Rural
    • Dairy farming
    • Sheep & beef farming
    • Horticulture
    • Animal health
    • Rural business
    • Rural life
    • Rural technology
    • Opinion
    • Audio & podcasts
  • Weather forecasts
    • All Weather forecasts
    • Kaitaia
    • Whangārei
    • Dargaville
    • Auckland
    • Thames
    • Tauranga
    • Hamilton
    • Whakatāne
    • Rotorua
    • Tokoroa
    • Te Kuiti
    • Taumaranui
    • Taupō
    • Gisborne
    • New Plymouth
    • Napier
    • Hastings
    • Dannevirke
    • Whanganui
    • Palmerston North
    • Levin
    • Paraparaumu
    • Masterton
    • Wellington
    • Motueka
    • Nelson
    • Blenheim
    • Westport
    • Reefton
    • Kaikōura
    • Greymouth
    • Hokitika
    • Christchurch
    • Ashburton
    • Timaru
    • Wānaka
    • Oamaru
    • Queenstown
    • Dunedin
    • Gore
    • Invercargill
  • Meet the journalists
  • Promotions & competitions
  • OneRoof property listings
  • Driven car news

Puzzles & Quizzes

  • Puzzles
    • All Puzzles
    • Sudoku
    • Code Cracker
    • Crosswords
    • Cryptic crossword
    • Wordsearch
  • Quizzes
    • All Quizzes
    • Morning quiz
    • Afternoon quiz
    • Sports quiz

Regions

  • Northland
    • All Northland
    • Far North
    • Kaitaia
    • Kerikeri
    • Kaikohe
    • Bay of Islands
    • Whangarei
    • Dargaville
    • Kaipara
    • Mangawhai
  • Auckland
  • Waikato
    • All Waikato
    • Hamilton
    • Coromandel & Hauraki
    • Matamata & Piako
    • Cambridge
    • Te Awamutu
    • Tokoroa & South Waikato
    • Taupō & Tūrangi
  • Bay of Plenty
    • All Bay of Plenty
    • Katikati
    • Tauranga
    • Mount Maunganui
    • Pāpāmoa
    • Te Puke
    • Whakatāne
  • Rotorua
  • Hawke's Bay
    • All Hawke's Bay
    • Napier
    • Hastings
    • Havelock North
    • Central Hawke's Bay
    • Wairoa
  • Taranaki
    • All Taranaki
    • Stratford
    • New Plymouth
    • Hāwera
  • Manawatū - Whanganui
    • All Manawatū - Whanganui
    • Whanganui
    • Palmerston North
    • Manawatū
    • Tararua
    • Horowhenua
  • Wellington
    • All Wellington
    • Kapiti
    • Wairarapa
    • Upper Hutt
    • Lower Hutt
  • Nelson & Tasman
    • All Nelson & Tasman
    • Motueka
    • Nelson
    • Tasman
  • Marlborough
  • West Coast
  • Canterbury
    • All Canterbury
    • Kaikōura
    • Christchurch
    • Ashburton
    • Timaru
  • Otago
    • All Otago
    • Oamaru
    • Dunedin
    • Balclutha
    • Alexandra
    • Queenstown
    • Wanaka
  • Southland
    • All Southland
    • Invercargill
    • Gore
    • Stewart Island
  • Gisborne

Media

  • Video
    • All Video
    • NZ news video
    • Herald NOW
    • Business news video
    • Politics news video
    • Sport video
    • World news video
    • Lifestyle video
    • Entertainment video
    • Travel video
    • Markets with Madison
    • Kea Kids news
  • Podcasts
    • All Podcasts
    • The Front Page
    • On the Tiles
    • Ask me Anything
    • The Little Things
  • Cartoons
  • Photo galleries
  • Today's Paper - E-editions
  • Photo sales
  • Classifieds

NZME Network

  • Advertise with NZME
  • OneRoof
  • Driven Car Guide
  • BusinessDesk
  • Newstalk ZB
  • Sunlive
  • ZM
  • The Hits
  • Coast
  • Radio Hauraki
  • The Alternative Commentary Collective
  • Gold
  • Flava
  • iHeart Radio
  • Hokonui
  • Radio Wanaka
  • iHeartCountry New Zealand
  • Restaurant Hub
  • NZME Events

SubscribeSign In
Advertisement
Advertise with NZME.
Home / World

Weed, snail venom may replace addictive opioid pain killers

Washington Post
29 Jun, 2017 07:28 PM4 mins to read

Subscribe to listen

Access to Herald Premium articles require a Premium subscription. Subscribe now to listen.
Already a subscriber?  Sign in here

Listening to articles is free for open-access content—explore other articles or learn more about text-to-speech.
‌
Save

    Share this article

One of the more far-out medications in development is derived from a deadly toxin found in cone snails. Photo / 123RF

One of the more far-out medications in development is derived from a deadly toxin found in cone snails. Photo / 123RF

By Caroline Chen

In the wake of mounting overdoses and deaths from the opioid-addiction crisis sweeping the nation, drugmakers are racing to come up with safer painkillers.

Companies are highly motivated to create alternatives to the $4 billion opioid market. The federal government is cracking down on lax prescriptions that contribute to many thousands of deaths a year and has started to block the sale of medications it considers unsafe.

Drugs such as morphine, fentanyl, and oxycodone are such powerful analgesics because they so effectively block pain signals by acting directly on the brain. Since they work at such a fundamental level, these medications would be perfect painkillers were it not for their tendency to cause addiction.

"In medical school, we used to play this game: If you could only take five drugs to a desert island, what would they be? Everyone would say morphine because it's such a terrific drug for pain," said Morgan Sheng, vice president of neuroscience and molecular biology at Roche Holding AG's Genentech unit.

Advertisement
Advertise with NZME.
Advertisement
Advertise with NZME.

Drugmakers are tackling the challenge from all angles, working to create an arsenal of medications tailor-made for different forms of pain. These new drugs are drawing from the known pain-modifying attributes of Chilli peppers and cannabis, as well as human genetic mutations that alter how people experience pain to concoct new treatments for the nation's 100 million chronic sufferers. One of the more far-out medications in development is derived from a deadly toxin found in cone snails.

Many of these new innovations are intended to treat osteoarthritis pain, a huge market as the baby-boomer generation ages. Centrexion Therapeutics Corp. is developing an injection using synthetic capsaicin, the active ingredient in Chilli peppers. A mid-stage trial showed a single injection in patients' knees brought significant relief for as long as six months.

Capsaicin reduces the hyper-sensitive nerve endings in the knee, "like a hair cut," said Centrexion Chief Medical Officer Randall Stevens. The nerves will eventually grow back, requiring repeated treatment. The drug has the added benefit of not affecting nerves that sense touch and pressure, so the joint will retain some normal sensation, minus the most active pain sensors, said Chief Executive Officer Jeffrey Kindler.

Advertisement
Advertise with NZME.

Other new arthritis meds are nerve-growth-factor inhibitors, which block pain signals in nerve cells beyond the brain, such as in skin and muscle. This drug class was dogged by concerns that it worked so well, patients overused the affected joint. That led the U.S. Food and Drug Administration to issue temporary suspensions of some early trials. Pfizer Inc. and Eli Lilly & Co., which co-developed one of these drugs, have adjusted doses and now have the leading treatment, called tanezumab, which received fast-track review from the FDA on June 13.

Taking another tack, Genentech is developing an oral drug based on extremely rare genetic mutations that prevent people from feeling pain. Studying them helped scientists discover a pathway in the body called the Nav 1.7 sodium ion channel that's implicated in pain. By modulating the pathway, Genentech hopes its pill can tamp down suffering.

It's still early days. The drug, called GDC-0310, just completed a Phase 1 safety trial. Genentech's Sheng said he's hopeful it will have few serious side effects since humans with the mutated gene are otherwise normal, save for a loss of the sense of smell. Sheng said it should be effective against musculoskeletal pain, such as in the lower back. Amgen Inc. is also in the early stages of developing a Nav 1.7 blocking drug.

Other pre-clinical treatments include Cara Therapeutics Inc. and Centrexion experimental drugs that target the cannabinoid receptors, mimicking the analgesic effect of marijuana. Meanwhile, scientists at Hunter College in New York are working to make an intravenous painkiller based on a toxin found in cone snails.

Opioids probably won't ever be shelved for good -- they're just too potent. So a handful of companies are working on versions that are safer and less addictive. Nektar Therapeutics has created an opioid that's designed to cross the blood-brain barrier very slowly, which results in a lowered euphoric effect. Because of its slower entry into the brain, however, the drug won't be able to help with cases of acute pain. Nektar is developing it for patients with chronic lower backaches.

Trevena Inc., meanwhile, is working on a safer opioid for hospital use that doesn't slow patients' breathing like many current opioids do. Said CEO Maxine Gowen: "We're all longing for the day when a non-addictive pain therapy with no side effects comes along, but until we find that perfect drug, opioids will continue to have a place."

Save

    Share this article

Latest from World

World

Trump ‘very unhappy’ with Putin on Ukraine, hints at sanctions

05 Jul 06:38 AM
Entertainment

Cause of death revealed as Julian McMahon, 56, dies after private battle

05 Jul 04:42 AM
Sport

Emma Raducanu criticises Wimbledon electronic line calls after loss

05 Jul 03:26 AM

There’s more to Hawai‘i than beaches and buffets – here’s how to see it differently

sponsored
Advertisement
Advertise with NZME.

Latest from World

Trump ‘very unhappy’ with Putin on Ukraine, hints at sanctions

Trump ‘very unhappy’ with Putin on Ukraine, hints at sanctions

05 Jul 06:38 AM

US President frustrated after a chat with the Russian leader about the Ukraine war.

Cause of death revealed as Julian McMahon, 56, dies after private battle

Cause of death revealed as Julian McMahon, 56, dies after private battle

05 Jul 04:42 AM
Emma Raducanu criticises Wimbledon electronic line calls after loss

Emma Raducanu criticises Wimbledon electronic line calls after loss

05 Jul 03:26 AM
Texas flash flood death toll rises to 24

Texas flash flood death toll rises to 24

05 Jul 03:26 AM
From early mornings to easy living
sponsored

From early mornings to easy living

NZ Herald
  • About NZ Herald
  • Meet the journalists
  • Newsletters
  • Classifieds
  • Help & support
  • Contact us
  • House rules
  • Privacy Policy
  • Terms of use
  • Competition terms & conditions
  • Our use of AI
Subscriber Services
  • NZ Herald e-editions
  • Daily puzzles & quizzes
  • Manage your digital subscription
  • Manage your print subscription
  • Subscribe to the NZ Herald newspaper
  • Subscribe to Herald Premium
  • Gift a subscription
  • Subscriber FAQs
  • Subscription terms & conditions
  • Promotions and subscriber benefits
NZME Network
  • The New Zealand Herald
  • The Northland Age
  • The Northern Advocate
  • Waikato Herald
  • Bay of Plenty Times
  • Rotorua Daily Post
  • Hawke's Bay Today
  • Whanganui Chronicle
  • Viva
  • NZ Listener
  • Newstalk ZB
  • BusinessDesk
  • OneRoof
  • Driven Car Guide
  • iHeart Radio
  • Restaurant Hub
NZME
  • About NZME
  • NZME careers
  • Advertise with NZME
  • Digital self-service advertising
  • Book your classified ad
  • Photo sales
  • NZME Events
  • © Copyright 2025 NZME Publishing Limited
TOP